Drugs / Pathogen-reduced Biotin Labeled Red Blood Cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04426591 | Oct 2021 → Apr 2025 | sickle cell disease | Marianne Yee | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Pathogen-reduced Biotin Labeled Red Blood Cells | “Device: Pathogen-reduced Biotin Labeled Red Blood Cells” NCT04426591 ↗ |